Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

INSANE: The alliance for hippocratic medicine | Vintage Vibes

2026’s abortion battles will be fought more in courthouses and FDA offices than at the voting booth

In 2026, the biggest battles over abortion will not be at the polls.

The Conversation

Supreme Court’s blow to federal agencies’ power will likely weaken abortion rights – 3 issues to watch

The Supreme Court wrapped up its term at the beginning of July 2024 with a range of rulings that reshape everything from the power of the presidency to how federal agencies carry out their work.

The Conversation

US supreme court seems skeptical of arguments against abortion drug mifepristone

Decision in anti-abortion doctors’ favor would apply across US and would likely make the drug more difficult to acquire

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

U.S. Supreme Court takes up Texas case challenging abortion pill access

A majority of Supreme Court justices seemed open to keeping mifepristone, a common abortion-inducing drug, on the market despite a Texas ruling revoking its FDA approval.

The Texas Tribune

A Supreme Court abortion pill case with potential consequences for every other drug

At issue is the FDA's regulatory power to approve drugs and continually evaluate their safety — a system that until now has been widely viewed as the gold standard for both safety and innovation

WEKU

What's at Stake in the Supreme Court's Abortion Pill Case

The Court announced today that it would take up a case involving access to the abortion-inducing drug mifepristone.

Reason

Appeals Court Rules in Much-Anticipated Abortion Pills Case

Plus: Court urged to stop Arkansas' social media age verification law from taking effect in September, legalizing medical marijuana linked to lower insurance premiums, and more...

Reason

Read news from The Economist, FT, and more,
with one subscription

US appeals court upholds restrictions on abortion pill access

Ruling prevents mifepristone being prescribed by non-doctors or shipped by mail but does not order drug off market

The Guardian - US

Language and Abortion

On Press Coverage In The Mifepristone Case.

Reason

SCOTUS: Abortion pill is safe — for now

SCOTUS reversed a federal judge's previous ruling that banned mifepristone, a pill intrinsic to medication abortion

Salon

Abortion pill ruling: Texas judge orders hold on FDA approval, but another judge contradicts him

ATLANTA — A federal judge in Texas delivered a major blow to reproductive rights advocates Friday, ordering a hold on the Food and Drug Administration approval of mifepristone, an abortion medication used in the United States since 2000.

Los Angeles Times

Texas judge orders hold on FDA approval of abortion pill, but another ruling contradicts him

WASHINGTON — A federal judge in Texas delivered a major blow to reproductive rights advocates Friday, ordering a hold on the U.S. Food and Drug Administration approval of mifepristone, an abortion medication used in the United States since 2000.

Los Angeles Times

Texas judge orders hold on FDA approval of widely used abortion medication

Los Angeles Times

Cynthia M. Allen: Texas abortion pill case is no morality play. It’s a complex, technical squabble

Since a group of pro-life plaintiffs first challenged the Food and Drug Administration’s approval of mifepristone, one of the two drugs used in chemical or medication abortions, the reporting on the case has been predictable.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Department of Education

353 stories

Food and Drug Administration

343 stories

the Food and Drug Administration

the Department of Health and Human Services

the Alliance for Hippocratic Medicine

14 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.